☰

Sinan Zhu, Ph.D. - Publications

Affiliations: 
2013 Molecular Medicine and Translational Science Wake Forest University, Winston-Salem, NC, United States 
Area:
Oncology
Tree Info Grants Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Hassan MS, Pullikuth A, Nelson KC, Flores A, Karpova Y, Baiz D, Zhu S, Sui G, Huang Y, D'Agostino R, Hemal A, von Holzen U, Debinski W, Kulik G. Beta2-adrenoreceptor signaling increases therapy-resistance in prostate cancer by upregulating MCL1. Molecular Cancer Research : McR. PMID 32928910 DOI: 10.1158/1541-7786.Mcr-19-1037  0.501
2015 Ran L, Sirota I, Cao Z, Murphy D, Chen Y, Shukla S, Xie Y, Kaufmann MC, Gao D, Zhu S, Rossi F, Wongvipat J, Taguchi T, Tap WD, Mellinghoff IK, et al. Combined inhibition of MAP kinase and KIT signaling synergistically destabilizes ETV1 and suppresses GIST tumor growth. Cancer Discovery. 5: 304-15. PMID 25572173 DOI: 10.1158/2159-8290.Cd-14-0985  0.397
2014 Lee W, Teckie S, Wiesner T, Ran L, Prieto Granada CN, Lin M, Zhu S, Cao Z, Liang Y, Sboner A, Tap WD, Fletcher JA, Huberman KH, Qin LX, Viale A, et al. PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors. Nature Genetics. 46: 1227-32. PMID 25240281 DOI: 10.1038/Ng.3095  0.343
2013 Fry EA, Taneja P, Maglic D, Zhu S, Sui G, Inoue K. Dmp1α inhibits HER2/neu-induced mammary tumorigenesis. Plos One. 8: e77870. PMID 24205004 DOI: 10.1371/Journal.Pone.0077870  0.537
2013 Zhu S, Mott RT, Fry EA, Taneja P, Kulik G, Sui G, Inoue K. Cooperation between Dmp1 loss and cyclin D1 overexpression in breast cancer. The American Journal of Pathology. 183: 1339-50. PMID 23938323 DOI: 10.1016/J.Ajpath.2013.06.027  0.556
2013 Maglic D, Zhu S, Fry EA, Taneja P, Kai F, Kendig RD, Sugiyama T, Miller LD, Willingham MC, Inoue K. Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer. Oncogene. 32: 4120-9. PMID 23045280 DOI: 10.1038/Onc.2012.423  0.467
2012 Maglic D, Kendig R, Fry E, Zhu S, Inoue K. Abstract 4158: MEKK1 regulates DMP1 transcriptional activity via phosphorylation and predicts breast cancer patient outcome Cancer Research. 72: 4158-4158. DOI: 10.1158/1538-7445.Am2012-4158  0.52
2012 zhu s. Abstract 2052: Regulation of p16Ink4a - Rb pathway by Cyclin D1- Dmp1 interaction Cancer Research. 72: 2052-2052. DOI: 10.1158/1538-7445.Am2012-2052  0.485
2011 Zhu S, Taneja P, Kendig R, Kai F, Maglic D, Inoue K. Abstract 2958: Cyclin D1 regulates the ARF and INK4a promoters Cancer Research. 71: 2958-2958. DOI: 10.1158/1538-7445.Am2011-2958  0.482
2010 Taneja P, Maglic D, Kai F, Zhu S, Kendig RD, Fry EA, Inoue K. Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance. Clinical Medicine Insights. Oncology. 4: 15-34. PMID 20567632  0.316
Show low-probability matches.